article thumbnail

Florida doctors' board tightens ban on gender-affirming care

Medical Xpress

A prohibition against puberty blocking hormones and gender-affirming surgeries for minors in Florida was tightened further after a board overseeing doctors eliminated an exception for clinical trials Friday at the request of Florida Gov. Ron DeSantis' administration.

Doctors 94
article thumbnail

Hormone Therapy for Prostate Cancer May Raise Heart Risks

The Pharma Data

20, 2020 — Hormone therapy can be a lifesaver for men with prostate cancer , but it also appears to put some at increased risk of heart problems, a new study reports. Prostate cancer is fueled by male hormones, which are called androgens. But questions have arisen about the effects of long-term hormone therapy on heart health.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Pharmalittle: Merck ends late-stage trial for Keytruda in prostate cancer; doctor group says 60 Minutes segment on Wegovy was an ad

STAT News

The drug was being tested in combination with androgen deprivation therapy and Xtandi in patients with hormone-sensitive prostate cancer that has spread to other parts of the body.  The interim analysis showed the therapy did not extend survival or help extend the time a patient lives without the disease worsening.

Doctors 98
article thumbnail

Measuring endocrine disruptors in wastewater

Scienmag

Endocrine disruptors are chemicals that alter the hormonal systems and the development of organisms that are exposed to them, even in small quantities. Doctoral student Julie Robitaille and Professor Valérie Langlois of the Institut national de la recherche scientifique (INRS) are […].

article thumbnail

The Longevity Breakthrough Your Doctor Won't Tell You About

The Pharma Data

Product Name: The Longevity Breakthrough Your Doctor Won't Tell You About. Click here to get The Longevity Breakthrough Your Doctor Won't Tell You About at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

Doctors 52
article thumbnail

A treatment for a deadly condition in newborns fails to improve outcomes, study finds

STAT News

For babies born with hypoxic-ischemic encephalopathy, commonly called birth asphyxia, doctors have limited options. A new study , published Wednesday in the New England Journal of Medicine, found that the hormone erythropoietin did not improve survival and other outcomes in newborns with hypoxic-ischemic encephalopathy.

article thumbnail

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer

The Pharma Data

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer. Orgovyx, which was granted Priority Review by the FDA, is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist for men with advanced prostate cancer. Indication.